Literature DB >> 16985291

Preliminary human study for possible alteration of serum immunoglobulin E production in perennial allergic rhinitis with fermented milk prepared with Lactobacillus gasseri TMC0356.

Hirotsugu Morita1, Fang He, Manabu Kawase, Akira Kubota, Masaru Hiramatsu, Jun-Ichi Kurisaki, Seppo Salminen.   

Abstract

The fermented milk prepared with Lactobacillus gasseri TMC0356 was administered at 200 ml per day for 4 weeks to 15 subjects with high serum IgE levels and perennial allergic rhinitis. The serum total IgE concentration was significantly reduced after 28 days' exposure to the fermented milk (P <0.05) compared to that before the intervention. The serum IgE specific to Acari and those to Japanese cedar pollen also significantly declined (P <0.05). T helper 1 (Th1) cells in the composition of their peripheral blood mononuclear cells (PBMCs) significantly increased after 14 days (P <0.01) and after 28 days (P <0.05). These results suggest that the fermented milk prepared with L. gasseri TMC0356 may alter serum IgE concentration, at least partly by enhancement of Th1 immune responses of the subjects with high concentration of serum IgE. However, further studies are still necessary to know the underlying mechanisms by which the tested fermented milk could influence the host immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16985291     DOI: 10.1111/j.1348-0421.2006.tb03842.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  14 in total

Review 1.  Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data.

Authors:  O Ozdemir
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

2.  Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study).

Authors:  D J Costa; P Marteau; M Amouyal; L K Poulsen; E Hamelmann; M Cazaubiel; B Housez; S Leuillet; M Stavnsbjerg; P Molimard; S Courau; J Bousquet
Journal:  Eur J Clin Nutr       Date:  2014-02-26       Impact factor: 4.016

3.  Probiotics: Potent Immunomodulatory Tool Against Allergy.

Authors:  Umesh Kr Shandilya; Sagar Jadhav; Vandana Panwar; V K Kansal
Journal:  Probiotics Antimicrob Proteins       Date:  2011-12       Impact factor: 4.609

4.  Lactobacillus gasseri attenuates allergic airway inflammation through PPARγ activation in dendritic cells.

Authors:  Miao-Hsi Hsieh; Ren-Long Jan; Lawrence Shih-Hsin Wu; Pei-Chi Chen; Hui-Fang Kao; Wen-Shuo Kuo; Jiu-Yao Wang
Journal:  J Mol Med (Berl)       Date:  2017-10-14       Impact factor: 4.599

5.  The role of probiotics in allergic diseases.

Authors:  Sonia Michail
Journal:  Allergy Asthma Clin Immunol       Date:  2009-10-22       Impact factor: 3.406

6.  Hyperglycemia-Induced Cardiac Damage Is Alleviated by Heat-Inactivated Lactobacillus reuteri GMNL-263 via Activation of the IGF1R Survival Pathway.

Authors:  Ker-Ping Koay; Wei-Wen Kuo; Bruce Chi-Kang Tsai; Chia-Hua Kuo; Hsiang-Ning Luk; Cecilia Hsuan Day; Ray-Jade Chen; Michael Yu-Chih Chen; V Vijaya Padma; Chih-Yang Huang
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02-01       Impact factor: 4.609

7.  MyD88 associated ROS generation is crucial for Lactobacillus induced IL-12 production in macrophage.

Authors:  Shintaro Ichikawa; Mika Miyake; Rei Fujii; Yutaka Konishi
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

8.  Probiotic and cultural characteristic of strain Lactobacillus gasseri 4/13 of human origin.

Authors:  Kalinka Baltova; Zhechko Dimitrov
Journal:  Biotechnol Biotechnol Equip       Date:  2014-10-31       Impact factor: 1.632

Review 9.  Treatment of allergic rhinitis with probiotics: an alternative approach.

Authors:  Gui Yang; Zhi-Qiang Liu; Ping-Chang Yang
Journal:  N Am J Med Sci       Date:  2013-08

Review 10.  Allergic diseases among children: nutritional prevention and intervention.

Authors:  Mohamed A Hendaus; Fatima A Jomha; Mohammad Ehlayel
Journal:  Ther Clin Risk Manag       Date:  2016-03-07       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.